Brief Communication: Sexual dimorphic expression of myostatin and follistatin like-3 in a rat trans-generational under-nutrition model
© Peiris et al; licensee BioMed Central Ltd. 2010
Received: 7 December 2009
Accepted: 20 May 2010
Published: 20 May 2010
The detrimental effects of maternal under-nutrition during gestation on fetal development are well known with an increased propensity of metabolic disorders identified in the adult offspring. Understanding exactly how and by which molecular pathways inadequate nutrition can impact upon offspring phenotype is critical and necessary for the development of treatment methods and ultimately prevention of any negative health effects. Myostatin, a negative regulator of muscle development, has recently been shown to effect glucose homeostasis and fat deposition. The involvement of myostatin in glucose metabolism and adipogenesis thus supports its ability to act in the continued alterations to the postnatal phenotype of the offspring. This hypothesis was examined in the current study using a trans-generational gestationally under-nourished rat model exposed to a high-fat (HF) diet post-weaning. The body weight, body fat, plasma glucose and insulin concentrations of the offspring, both male and female, were investigated in relation to the protein expression of myostatin and its main inhibitor; follistatin like-3 (FSTL-3), in skeletal muscle of mature offspring. Sexual dimorphism was clearly evident in the majority of these measures, including myostatin and FSTL-3 expression. Generally males displayed higher (P < 0.05) myostatin precursor and dimer expression than females, which was especially apparent (P < 0.01) in both chow and HF trans-generationally undernourished (UNAD) groups. In females only, myostatin precursor and dimer expression was altered by both trans-generational under-nutrition and postnatal diet. Overall FSTL-3 expression did not differ between sexes, although difference between sexes within certain treatments and diets were evident. Most notably, HF fed UNAD females had higher (P < 0.05) FSTL-3 expression than HF fed UNAD males. The former group also displayed higher (P < 0.01) FSTL-3 expression compared to all other female groups. In summary, myostatin may prove to be a key mediator of the effects of inadequate prenatal nutrition, independently or in combination with a high-fat postnatal diet on offspring phenotype. Consequently, further study of myostatin may provide a novel therapeutic pathway for the treatment of metabolic disorders; however, it is vital that the influence of nutrition and gender should be taken into consideration.
Myostatin initially designated as growth differentiation factor 8 (GDF-8), is a distinctive member of the TGF-β super-family, retaining many of the characteristic features found in this family . The functional importance of myostatin is inferred by the high level of sequence homology and conservation seen across a number of species. Synthesized as a precursor protein, myostatin is proteolytically cleaved twice to release the biologically mature form of myostatin, with dimerisation of the mature protein creating the active form of myostatin . The binding of the myostatin dimer to its receptor (ActRIIB) initiates the Smad mediated signaling pathway, which results in the transcription and expression of genes needed to mediate the negative regulation of muscle development. Myostatin function is controlled by a number of inhibitors, the most potent being follistatin like-3 (FSTL-3) .
Myostatin was initially identified as a negative regulator of muscle development where its inactivation in mice resulted in offspring with a two to three-fold increase in muscle mass . Subsequently, myostatin was identified to affect glucose uptake in the human placenta . Recently, altered placenta myostatin concentrations were identified in developmentally programmed rat model that supports a role as a mediator of this phenomenon . Myostatin has also been shown to be crucial in the modulation of glucose homeostasis and adipogenesis [6, 7]. The aim of this study was to utilise a model of trans-generational maternal under-nutrition to investigate potential sexual dimorphic changes in the expression of myostatin and FSTL-3 in rat skeletal muscle.
Materials and methods
F1 females litter size was standardized on D1 to 10 pups, 5 males and 5 females where possible. All these F2 pups were nursed by their own dams that were fed AD until weaning (D22). At weaning half the offspring from each of the three groups were fed either a chow or high fat (HF, 60% kcal as fat; D12492 Research Diets Inc, NJ, USA) diet ad libitum until being euthanized at D140. The body weights of F2 animals were recorded from birth until D140. On D130, body measurements and composition were determined in F2 animals (n = 10 per sex per diet per group) by DEXA using a LUNAR Prodigy Scanner (GE Medical Systems, WI, USA). On D140 after an overnight fast, the animals were euthanised via decapitation under sodium pentobarbital anesthesia (60 mg kg, I.P.). Blood was collected, centrifuged for 15 mins at 1500 × g at 4°C and stored at -20°C for further analysis. Skeletal muscle samples were collected from the left hind leg quadriceps, snap frozen and stored at -80°C. All animal procedures undertaken were approved by the University of Auckland Animal Ethics Committee.
Plasma glucose was measured along with quality controls using commercial kits (Roche Diagnostics Corp.; IN, USA) on an auto-analyzer (Roche/Hitachi 9002 Analyzer; Hitachi, Tokyo, Japan). Plasma insulin was determined by a rat insulin ELISA (Mercodia; Uppsala, Sweden) following the manufacturers' instructions. The insulin assay sensitivity was 0.07 μg/l and the intra- and inter-assay coefficients of variation (CVs) were 3.4% and 6.3%.
Protein extraction and Western blotting
Proteins were extracted from male and female D140 muscle samples and Western blot analysis performed [11, 12]. Antibodies from Santa Cruz Biotechnology (CA, USA) were used for the detection of myostatin (1:3000 dilution; Goat Polyclonal GDF-8 (F-13), Sc-34781) and FSTL-3 (1:5000 dilution; Goat Polyclonal FLRG (N-18), Sc-21302) in conjunction with a secondary Polyclonal Rabbit Anti IgG/HRP antibody (1:10000 dilution). The relative optical densities were normalized to sheep muscle expression of myostatin and FSTL-3 protein.
All analyses were run using a general linear mixed model followed by Tukey's post hoc comparison performed on SAS software version 9.1 (SAS institute, Cavy, NC). Differences in bodyweight and composition, plasma metabolite concentrations and the relative expression of myostatin and FSTL-3 in skeletal muscle were analysed with group, sex and diet included in the model, and all interactions between the main effects were analysed. All data presented are as means ± SEM.
Mature female and male body weight, body fat percentage and lean body percentage.
Body fat %
Lean Body %
Mean ± SEM
Mean ± SEM
Mean ± SEM
Mean ± SEM
Mean ± SEM
Mean ± SEM
323.9 ± 10.4 ax
564.6 ± 13.5 ay
25.9 ± 2.2 ax
27.0 ± 2.3 acx
66.23 ± 2.93 ax
66.64 ± 1.91 ax
273.5 ± 11.2 bx
528.3 ± 12.2 by
17.7 ± 2.0 bx
24.9 ± 2.2 acy
73.68 ± 0.61 bx
69.38 ± 1.61 abx
305.5 ± 10.8 adx
552.9 ± 8.4 aby
23.4 ± 2.2 abx
25.9 ± 2.2 acx
67.70 ± 1.99 abx
67.04 ± 1.57 adx
High fat fed
365.8 ± 10.4 cx
692.5 ± 39.1 cy
39.1 ± 2.2 cx
40.9 ± 2.3 bx
53.42 ± 3.79 bcx
52.73 ± 1.62 bx
308.7 ± 11.7 bdx
621.6 ± 11.7 dy
27.0 ± 2.2 adx
41.4 ± 2.2 by
64.63 ± 1.86 ax
52.10 ± 1.21 cy
335.6 ± 10.8 adx
636.7 ± 30.8 ey
30.8 ± 2.2 adx
32.5 ± 2.2 cx
61.16 ± 2.00 adx
61.68 ± 3.83 adx
Mature female and male plasma insulin and glucose concentrations.
Mean ± SEM
Mean ± SEM
Mean ± SEM
Mean ± SEM
2.2 ± 0.4 abx
2.0 ± 0.6 ax
8.6 ± 0.3 ax
8.5 ± 0.4 abx
1.5 ± 0.4 ax
3.5 ± 0.5 bcy
8.3 ± 0.3 ax
8.8 ± 0.4 abx
1.6 ± 0.4 ax
2.5 ± 0.3 aby
9.1 ± 0.3 ax
8.1 ± 0.2 ay
High fat fed
2.9 ± 0.4 bcx
4.0 ± 0.6 bcx
8.7 ± 0.3 ax
9.1 ± 0.4 bx
3.1 ± 0.5 bcx
3.1 ± 0.5 abcx
8.9 ± 0.3 ax
8.1 ± 0.3 ax
3.6 ± 0.4 cx
4.1 ± 0.3 bcx
10.2 ± 0.3 bx
9.4 b ± 0.2 by
Sexually dimorphic differences were evident in the phenotypic measures investigated and notably, the skeletal muscle expression of myostatin and FSTL-3 proteins. The majority of these measures were also impacted upon by gestational and trans-generational under-nutrition and postnatal diet.
Generally higher myostatin precursor and dimer expression was identified in the males compared to females, whereas a consistent dimorphic difference in FSTL-3 expression was not evident; with only a few specific groups within diet showing differences. The increased expression of myostatin precursor in skeletal muscle of males compared to females is in agreement with studies in mice [13, 14]. In contrast however to our study, these studies in mice identified the myostatin dimer expression, unlike the precursor, to be higher in females, which is surprising since it would be expected that both precursor and dimer had increased expression in the same sex, as in the current study. Species specific differences in myostatin dimer expression and the use of different antibodies between the two studies in order to detect the dimer, and thus potentially different binding sites, may however explain the discrepancy.
In this study, irrespective of sex, the expression of FSTL-3, myostatin precursor and dimer were varied in the UNAD HF fed offspring. This matches the phenotypic data, as UNAD animals fed an HF diet post-weaning, irrespective of sex, were lighter and had a reduced percentage body fat than ADAD animals, as well as ADUN animals (males only). Recently, the finding that myostatin maintained adipocytes at an immature state and thus influenced fat mass , suggest myostatin can affect two different processes; fat deposition and glucose uptake. Phenotypic differences in body composition were also linked to changes in plasma metabolite concentrations, as plasma glucose and insulin concentrations were elevated in the UNAD group (mainly in females) demonstrating hyperglycaemia, compared to the two other groups. Higher blood glucose concentrations, as evident in diabetes, are known to lead to reduced body weight of offspring [15, 16]. The increased plasma glucose concentrations evident in UNAD offspring could be influenced by the expression of myostatin and FSTL-3 in skeletal muscle, with limited fiber number and size potentially restricting uptake of glucose from the circulation, although further studies are needed to examine this hypothesis. If true, myostatin may be a possible mediator of offspring metabolic and physical phenotype.
Myostatin and FSTL-3 are sexually dimorphic in their expression and both are also affected by gestational and trans-generational under-nutrition. Thus myostatin may be a key mediator of the effects of maternal under-nutrition; altering fetal development, the mature phenotype of offspring, and even the phenotype of subsequent generations. Further study of myostatin may provide a novel therapeutic pathway for the treatment of metabolic disorders; however, it is vital that the influence of nutrition and gender should be taken into consideration.
Activin receptor IIB
shows F0: fed AD diet during gestation (AD)
fed AD diet during gestation (AD)
shows F0: fed AD diet during gestation (AD)
fed 30% of AD diet during gestation (UN)
Day followed by the number of days e.g. D140
Dual Energy X-ray Absorptiometry
Growth differentiation factor 8
Drosophila protein, combination of mothers against decapentaplegic (MAD) and the C. elegans protein (SMA)
Transforming Growth Factor-beta
30% of the ad libitum diet during gestation
shows F0: fed 30% AD diet during gestation (UN)
fed AD diet during gestation (AD).
The authors thank for their technical assistance with the animal studies Alice Coveny and Lara Kimble. The research was supported by grants from the Maurice and Phyllis Paykel Trust, New Zealand and The National Research Centre for Growth and Development (NRCGD), New Zealand awarded to MPG and The Faculty Research Development Fund, University of Auckland, New Zealand awarded to APP.
- Rodgers BD, Garikipati DK: Clinical, agricultural, and evolutionary biology of myostatin: A comparative review. Endocr Rev. 2008, 29: 513-534. 10.1210/er.2008-0003.View ArticleGoogle Scholar
- Lee SJ: Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol. 2004, 61-86. 10.1146/annurev.cellbio.20.012103.135836.Google Scholar
- McPherron AC, Lawler AM, Lee SJ: Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature. 1997, 387 (6628): 83-90. 10.1038/387083a0.View ArticleGoogle Scholar
- Mitchell MD, Osepchook CC, Leung K-C, McMahon CD, Bass JJ: Myostatin is a human placental product that regulates glucose uptake. J Clin Endocrinol Metab. 2006, 91: 1434-1437. 10.1210/jc.2005-2361.View ArticleGoogle Scholar
- Peiris HN, Ponnampalam AP, Mitchell MD, Green MP: Placental expression of myostatin and follistatin-like-3 protein in a model of developmental programming. Am J Physiol Endocrinol Metab. 2010, 298 (4): E854-61. 10.1152/ajpendo.00673.2009.View ArticleGoogle Scholar
- Feldman BJ, Streeper RS, Farese RV, Yamamoto KR: Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci USA. 2006, 103: 15675-15680. 10.1073/pnas.0607501103.View ArticleGoogle Scholar
- Zhao B, Wall RJ, Yang J: Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance. Biochem Biophys Res Commun. 2005, 337: 248-255. 10.1016/j.bbrc.2005.09.044.View ArticleGoogle Scholar
- Woodall SM, Breier BH, Johnston BM, Gluckman PD: A model of intrauterine growth retardation caused by chronic maternal under-nutrition in the rat: Effects on the somatotrophic axis and postnatal growth. J Clin Endocrinol. 1996, 150: 231-242.View ArticleGoogle Scholar
- Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD: Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab. 2000, 279: E83-E87.Google Scholar
- Vickers MH, Gluckman PD, Coveny AH, Hofman PL, Cutfield WS, Gertler A, Breier BH, Harris M: Neonatal leptin treatment reverses developmental programming. Endocrinology. 2005, 146: 4211-4216. 10.1210/en.2005-0581.View ArticleGoogle Scholar
- Antony N, Bass JJ, McMahon CD, Mitchell MD: Myostatin regulates glucose uptake in BeWo cells. Am J Physiol Endocrinol Metab. 2007, 293: E1296-E1302. 10.1152/ajpendo.00331.2007.View ArticleGoogle Scholar
- Evseenko DA, Murthi P, Paxton JW, Reid G, Emerald BS, Mohankumar KM, Lobie PE, Brennecke SP, Kalionis B, Keelan JA: The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction. FASEB J. 2007, 21: 3592-3605. 10.1096/fj.07-8688com.View ArticleGoogle Scholar
- McMahon CD, Popovic L, Jeanplong F, Oldham JM, Kirk SP, Osepchook CC, Wong KWY, Sharma M, Kambadur R, Bass JJ: Sexual dimorphism is associated with decreased expression of processed myostatin in males. Am J Physiol Endocrinol Metab. 2003, 284: E377-E381.View ArticleGoogle Scholar
- Oldham JM, Osepchook CC, Jeanplong F, Falconer SJ, Matthews KG, Conaglen JV, Gerrard DF, Smith HK, Wilkins RJ, Bass JJ, McMahon CD: The decrease in mature myostatin protein in male skeletal muscle is developmentally regulated by growth hormone. J Physiol. 2009, 587: 669-677. 10.1113/jphysiol.2008.161521.View ArticleGoogle Scholar
- Yamada R, Griggo MA, Luz J: Energy balance of pregnant diabetic rats. Br J Nutr. 2002, 87: 509-515. 10.1079/BJN2001520.View ArticleGoogle Scholar
- Nasu R, Seki K, Nara M, Murakami M, Kohama T: Effect of a high-fat diet on diabetic mother rats and their offspring through three generations. Endocrine J. 2007, 54: 563-569. 10.1507/endocrj.K06-175.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.